On April 22, Huitianfu Fund purchased an additional 79,000 shares of REMEGEN (09995) at a price of HK$113.7788 per share. The total transaction amounted to approximately HK$8.9885 million. Following this acquisition, the fund's total holdings in the company have reached 10.4965 million shares, representing a 5.03% stake.